HOOKIPA Pharma Inc.
HOOK
$0.7896
-$0.0354-4.29%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -81.72% | -31.51% | -51.85% | 1,052.36% | -5.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -81.72% | -31.51% | -51.85% | 1,052.36% | -5.38% |
| Cost of Revenue | -41.20% | -36.79% | -49.35% | -3.65% | 22.60% |
| Gross Profit | 17.01% | 38.83% | -52.17% | 192.54% | -48.88% |
| SG&A Expenses | 20.03% | 37.05% | -11.25% | -17.26% | 8.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -27.48% | -24.51% | -1.89% | -6.23% | 19.24% |
| Operating Income | 5.32% | 22.39% | -4.34% | 154.62% | -33.42% |
| Income Before Tax | -1.63% | 27.40% | -5.99% | 173.85% | -104.06% |
| Income Tax Expenses | -164.63% | -- | -- | -- | -28.38% |
| Earnings from Continuing Operations | -0.53% | 27.40% | -5.99% | 173.08% | -101.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.53% | 27.40% | -5.99% | 173.08% | -101.59% |
| EBIT | 5.32% | 22.39% | -4.34% | 154.62% | -33.42% |
| EBITDA | 2.29% | 23.84% | -5.26% | 159.88% | -32.85% |
| EPS Basic | 9.56% | 36.09% | 30.09% | 142.09% | -29.42% |
| Normalized Basic EPS | -57.10% | 40.94% | 30.29% | 146.29% | 36.83% |
| EPS Diluted | 9.56% | 36.09% | 30.14% | 140.37% | -29.42% |
| Normalized Diluted EPS | -57.10% | 40.94% | 30.29% | 146.07% | 36.83% |
| Average Basic Shares Outstanding | 11.16% | 13.59% | 51.61% | 73.62% | 55.77% |
| Average Diluted Shares Outstanding | 11.16% | 13.59% | 51.61% | 74.44% | 55.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
